Clinical trial
Pentoxifylline in Duchenne Muscular Dystrophy
NCT00102453 · Cooperative International Neuromuscular Research Group, Other · Completed
Key facts
| NCT number | NCT00102453 |
|---|---|
| Title | Pentoxifylline in Duchenne Muscular Dystrophy |
| Official title | An Open-Label Pilot Study of Pentoxifylline in Steroid-naive Duchenne Muscular Dystrophy |
| Lead sponsor | Cooperative International Neuromuscular Research Group, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Muscular Dystrophy, Duchenne |
| Intervention type | Drug |
| Interventions | Pentoxifylline |
| Enrollment | 17 |
| Start date | Mar 1, 2002 |
| Primary completion | Jul 1, 2006 |
| Completion | May 1, 2007 |
| First posted | Jan 31, 2005 |
| Last update posted | Oct 27, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: